Press release
Four Interactive Sessions to Take Place at the 2019 Respiratory Drug Delivery Conference
Respiratory Drug Delivery Conference
SMi is pleased to provide attendees with the opportunity to take part in over five hours of interactive sessions as part of the two-day conference. The interactive sessions will focus on novel routes of drug distribution and long-term solutions to dealing with the needs of patients.
The inaugural conference is part of SMi’s newly branded Asthma and COPD series and will bring together clinical researchers, respiratory drug manufacturers and solution providers to present and discuss the latest developments in respiratory drug delivery.
More details can be found here: www.respiratorydrugdelivery.com/openpr6
Interactive Session 1: “Novel Approaches to characterise Aerosol Dynamics”
Key topics:
• Introductory overview and case studies highlighting the reality of different characterisation approaches
• Assessing Drug Delivery methods, discussing mechanisms and dynamic breakup
• Reviewing the effects of the lung environment, including heat and relative humidity and why do dynamics matter in drug delivery?
Dr David Lewis, Aerosil Science Director Drug Delivery Technologies, Chiesi
Interactive Session 2: “Digital Enablement: could remote photoplethysmograpy be key to patient monitoring compliance?”
Key topics:
• Assessing the ability for remote photoplethysmographic (rPPG) technologies to solve the challenges of compliance in patient self-monitoring
• Reviewing the value of such technologies in predicting and preventing respiratory exacerbations
• Considering the barriers to adoption of mass rPPG monitoring
Laurence Pearce, Founder and CEO, Xim Ltd.
Interactive Session 3: “Respiratory drug delivery: what may the future hold?”
Key Topics:
• Setting the scene for how intelligent drug delivery can transform the field of respiration and assessing the emerging technologies landscape for improved respiratory drug delivery
• Discussion on benefits and challenges of nasal route for drug administration
Mayur Patel, Leading innovative medical and combination product development, PA Consulting
Interactive Session 4: Device Discovery: How relevant is a device to the patient
Key topics:
• Introduction to device discovery
• Open discussion on real world studies and feedback on hurdles
• Reviewing the operational challenges of RWS
• Assessing what the data challenges are once a study is up and running
Abid Raza, Respiratory Medicine, Independent Medical Expert
Registrations for the conference can be made online at www.respiratorydrugdelivery.com/openpr6 Register by the 31st October to save £100 off the conference price.
Respiratory Drug Delivery
5th – 6th December 2019
Copthorne Tara Hotel, London, UK
For delegate enquiries please contact Hakam Panum on +44 (0) 20 7827 6128 or hpanum@smi-online.co.uk
For sponsorship enquiries please contact Alia Malick on +44 (0) 207 827 6168 or amalick@smi-online.co.uk
India House, 45 Curlew Street, London, SE1 2ND
About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Four Interactive Sessions to Take Place at the 2019 Respiratory Drug Delivery Conference here
News-ID: 1845571 • Views: …
More Releases from SMi Group
Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Con …
SMi Reports: Exclusive speaker interview with Todd Krueger at AOBiome released for the Pain Therapeutics Conference
The pain therapeutics industry has grown at an exponential rate in recent years. The 22nd Annual Pain Therapeutics conference will cover the leading advances in pain therapeutics, exploring late development clinical trials, novel treatments for chronic conditions, technology collaboration treatments, using VR and Medical Devices that carry out non-invasive nerve stimulation.
Industry leaders will uncover the…
Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual High …
Now in its 6th year, the Highly Potent Active Pharmaceutical Ingredients conference offers you peer-to-peer networking with industry experts including heads and directors of EHS, Occupational Hygiene, Quality Assurance and more. Taking place on 9th and 10th May in London, UK.
With a key focus on expanding your community and exploring the latest developments in the industry at this two-day event, including key regulatory updates, and leading case studies from leading…
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast C …
SMi Group Reports: Keynote FDA speaker Dr. John Arigo, to present at the 4th Annual Pharmaceutical Microbiology East Coast, taking place in just 3 weeks' time on April 27th and 28th, 2022.
With just three weeks remaining until the highly anticipated conference, SMi Group are delighted to announce a key FDA Speaker joining the 5th Annual Pharmaceutical Microbiology East Coast Conference. This event will take place on April 27th and…
Group Captain (ret'd) Robert Daisley invites you to attend Air Mission Planning …
SMi Group reports: Chairman Group Captain (ret'd) Robert Daisley of the Air Mission Planning and Support Conference cordially invites experts to join the conference in London, UK in one week.
With only one week remaining, SMi Group is delighted to publish an invitation letter for SMi's 13th Annual Air Mission Planning & Support Conference, taking place on the 6th and 7th April 2022 in London, UK from the conference chairman.
The…
More Releases for Respiratory
Prevalence Of Respiratory Diseases Fuels Demand For Respiratory Disposables: Key …
The Respiratory Disposables Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Respiratory Disposables Market Size During the Forecast Period?
The respiratory disposables market has seen rapid growth in recent years. It is expected to grow from $1.01 billion in 2024 to $1.15…
Transforming the Respiratory Monitoring Devices Market in 2025: Rising Incidence …
What Is the Expected Size and Growth Rate of the Respiratory Monitoring Devices Market?
The market size for respiratory monitoring devices has seen swift expansion in the recent past. The market's growth is projected to increase from $1.67 billion in 2024 to $1.87 billion in 2025, with a compound annual growth rate (CAGR) of 11.8%. A combination of factors such as the prevalence of respiratory ailments, an aging demographic, technological innovations,…
Transforming the Respiratory Monitoring Devices Market in 2025: Rising Incidence …
What Is the Expected Size and Growth Rate of the Respiratory Monitoring Devices Market?
The market size for respiratory monitoring devices has seen swift expansion in the recent past. The market's growth is projected to increase from $1.67 billion in 2024 to $1.87 billion in 2025, with a compound annual growth rate (CAGR) of 11.8%. A combination of factors such as the prevalence of respiratory ailments, an aging demographic, technological innovations,…
Molecular Respiratory Panels Market: Enhancing Accuracy and Speed in Respiratory …
Introduction
The global molecular respiratory panels market is rapidly evolving, driven by the need for faster, more accurate diagnostics in respiratory diseases. With respiratory infections and diseases becoming increasingly prevalent worldwide, accurate detection and timely diagnosis are critical to improving patient outcomes. Molecular respiratory panels, which utilize advanced molecular techniques like PCR (Polymerase Chain Reaction) and other nucleic acid-based methods, enable the rapid identification of pathogens responsible for respiratory conditions. These…
Tackling Respiratory Challenges: Lower Respiratory Tract Therapeutics Market 202 …
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.
Lower Respiratory Tract Therapeutics Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $48.37 billion In…
Respiratory Assist Devices Market - Breathing Uninterrupted: Innovating Respirat …
Newark, New Castle, USA - new report, titled Respiratory Assist Devices Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Respiratory Assist Devices market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Respiratory Assist Devices market. The report offers an overview of…
